Cadence · 15 hours ago
Intern – Scientific Developer Target Exploration
Cadence is an industry leader in computational molecular design, and they are seeking an intern to work on the cutting edge of cloud computing and scientific software development. The role involves leveraging molecular dynamics simulations to gain insights into drug molecules and collaborating with scientists to enhance modeling efforts.
AerospaceElectronic Design Automation (EDA)HardwareMobileSemiconductorSoftware
Responsibilities
Building on tools for analyzing molecular dynamics simulations
Translating simulation information to understand properties of drug molecules
Collaborating with scientists from various backgrounds in computational drug discovery
Qualification
Required
Graduate student or advanced undergraduate student in a relevant field of inquiry (Physics, Chemistry, Structural Biology, Computer Science)
Introductory-to-Intermediate software development experience (specifically Python; though experience with other languages like Java, Julia, Swift, C(++), etc. may suffice)
Familiarity with undergraduate-level introductory biology, chemistry, and physics
Preferred
Familiarity with Structural Biology (specifically X-ray Crystallography/Cryo-EM) or AI/ML protein structure prediction
Experience with scientific software development in Python (numpy, scipy, matplotlib, pandas, etc.)
Experience with Molecular Dynamics software (GROMACS, AMBER, NAMD, MDTraj, OpenMM, etc.)
Company
Cadence
Cadence is a market leader in AI and digital twins, pioneering the application of computational software to accelerate innovation in the engineering design of silicon to systems.
H1B Sponsorship
Cadence has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (306)
2024 (221)
2023 (282)
2022 (330)
2021 (233)
2020 (209)
Funding
Current Stage
Public CompanyTotal Funding
unknown1998-02-20IPO
Leadership Team
Recent News
GlobeNewswire
2026-01-16
2026-01-07
Company data provided by crunchbase